EGFR Genotype as a Predictor of Survival in EGFR Mutant Non-Small Cell Lung Cancer

被引：0
|
作者：
Syrigos, K. [1 ]
Tsagouli, S. [1 ]
Gkiozos, I. [1 ]
Paraskeva, M. [1 ]
Kotteas, I. [1 ]
Tsimpoukis, S. [1 ]
Zontanos, M. [1 ]
Grapsa, D. [1 ]
机构：
[1] Univ Athens, Athens, Greece
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
non-small cell lung cancer; genotype; EGFR mutations;
D O I：
10.1016/j.jtho.2018.08.1655
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-95
引用
收藏
页码：S903 / S903
页数：1
相关论文
共 50 条
  • [1] Prognostic value of EGFR genotype in EGFR-mutant non-small cell lung cancer
    Syrigos, Konstantinos
    Kotteas, Ilias
    Paraskeva, Maria
    Gkiozos, Ioannis
    Boura, Paraskevi
    Tsagouli, Sofia
    Grapsa, Dimitra
    Charpidou, Andriani
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [2] Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer
    Loong, Herbert H.
    Kwan, Sui-chun Sampson
    Mok, Tony Shu-kam
    Lau, Yat-ming
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (11)
  • [3] Bone Metastasis in EGFR Mutant Non-Small Cell Lung Cancer
    Huang, Shu-Mei
    Yang, Jin-Ji
    Huang, Yi-Sheng
    Chen, Hua-Jun
    Bai, Xiao-Yan
    Zhou, Qing
    Tu, Han-Yan
    Wu, Yi-Long
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S766 - S767
  • [4] Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer
    Herbert H. Loong
    Sui-chun Sampson Kwan
    Tony Shu-kam Mok
    Yat-ming Lau
    [J]. Current Treatment Options in Oncology, 2018, 19
  • [5] EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
    Otsuka, Kyoko
    Hata, Akito
    Takeshita, Jumpei
    Okuda, Chiyuki
    Kaji, Reiko
    Masago, Katsuhiro
    Fujita, Shiro
    Katakami, Nobuyuki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 835 - 841
  • [6] EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
    Kyoko Otsuka
    Akito Hata
    Jumpei Takeshita
    Chiyuki Okuda
    Reiko Kaji
    Katsuhiro Masago
    Shiro Fujita
    Nobuyuki Katakami
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 76 : 835 - 841
  • [7] Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung Cancer
    Digumarthy, Subba R.
    Mendoza, Dexter P.
    Padole, Atul
    Chen, Tianqi
    Peterson, P. Gabriel
    Piotrowska, Zofia
    Sequist, Lecia, V
    [J]. CANCERS, 2019, 11 (09)
  • [8] For EGFR Mutant Non-Small Cell Lung Cancer, Treatment Sequence Matters?
    An, Ho Jung
    Shin, Yuneyoung
    Hong, Sook Hee
    Kim, Young Kyoon
    Kim, Seung Joon
    Lee, Kyo-Young
    Kang, Jin Hyoung
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S436 - S437
  • [9] Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
    Yan, Dan
    Earp, H. Shelton
    DeRyckere, Deborah
    Graham, Douglas K.
    [J]. CANCERS, 2021, 13 (22)
  • [10] Mechanisms of EGFR-TKI induced cell death and resistance in EGFR mutant non-small cell lung cancer
    Ko, J.
    Kim, Y.
    Park, M.
    Cui, Z.
    Ahn, M.
    Park, K.
    [J]. EJC SUPPLEMENTS, 2008, 6 (09): : 29 - 30
12345